This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016;5(2):110.

doi: 10.2217/cns.16.1. Epub 2016 Jan 6.

No authors listed

No authors listed. CNS Oncol. 2016.

. 2016;5(2):110.

doi: 10.2217/cns.16.1. Epub 2016 Jan 6.

No abstract available

ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma.
Gatson NT, Weathers SP, de Groot JF. Gatson NT, et al. CNS Oncol. 2016;5(1):11-26. doi: 10.2217/cns.15.38. Epub 2015 Dec 15. CNS Oncol. 2016. Retraction in: CNS Oncol. 2016;5(2):110. doi: 10.2217/cns.16.1. PMID: 26670466 Free PMC article. Retracted.